Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.
By Fujie Xu, M. Sternberg, B. Kottiri, G. Mcquillan, F. Lee, A. Nahmias, S. Berman, L. Markowitz. Journal of the American Medical Association (JAMA), 2006
1,027 citations recorded by the source corpus.
Subfields: Epidemiology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/f7ec968d5d806b121e5bcd081cdebf2573002090
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- G. D’Souza
- Y. Agrawal
- M. Gillison
- Jane L. Halpern
- S. Bodison
- M. Antônia dos Reis
- V. Teixeira
- Juliana Reis Machado
Citations in the corpus
- Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection (2009, result): “HSV-2 seroprevalence, a biomarker for sexual risk-taking, was also comparable among outpatient controls and NHANES participants (21% vs. 24% among 30 – 49 year olds) [15] and among college-aged men (5.2%), compared with 14- to 19-year-old men (0.9%) and 20- to 29-year-old men (5.6%) in NHANES [ 15 ]”
- Mucosal Immunity in the Female Genital Tract, HIV/AIDS (2014, background): “The incidence rates of genital herpes in HIVpositive women have been reported to vary between 11% and 50%; however, more than 80% of these patients are asymptomatic [262–264].”